Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Scott DeWire, PhD
US HEAD, BUSINESS DEVELOPMENT & LICENSING, BOEHRINGER INGELHEIM
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, Connecticut, United States
John DeYoung
VP, WORLDWIDE BUSINESS DEVELOPMENT – ONCOLOGY, PFIZER INC.
How to Strike a Deal in Oncology: Innovative Partnering Approaches Across Biotech and Pharma
New York, New York, United States
Rachel Diamant
CBO, EMENDOBIO
EmendoBio
NY, New York, United States
Jiao Dian
COUNSELLOR, ECONOMY AND COMMERCE SECTION, EMBASSY OF THE PEOPLE’S REPUBLIC OF CHINA IN THE UNITED STATES OF AMERICA
Understanding Business Development Opportunities in the Asia-Pacific
Christian Dimaano, PhD
VP, HEAD OF CLINICAL AFFAIRS, KINNATE BIOPHARMA
Oncology Drug Discovery: Novel Approaches To Drug Discovery
Gary Disbrow
DEPUTY ASSISTANT SECRETARY DIRECTOR, BARDA
Sustainable Innovation: Addressing 21st Century Health Security Threats (DoD/ASPR Engagement Day)
Anil Diwan, PhD
PRESIDENT & EXEC. CHAIRMAN, NANOVIRICIDES, INC.
NanoViricides, Inc.
Shelton, Connecticut, United States
Placeholder Photo
Victoria Dohnal
DIRECTOR, GLOBAL REGULATORY POLICY AND INTELLIGENCE, JANSSEN
40 years of the Orphan Drug Act, the Rare Disease Endpoint Advancement (RDEA) Pilot Program, and Transforming Rare Disease Development
Placeholder Photo
Lucas Donigian, MBA
EXECUTIVE DIRECTOR, BUSINESS DEVELOPMENT, ZYMEWORKS INC.
ZYMEWORKS INC.
Seattle, Washington, United States
Liam Donohue
CO-FOUNDER AND MANAGING PARTNER, 406 VENTURES
Investors' Perspectives: Digital Health Trends and Investment Thesis in 2023 and Beyond